Mithra Pharmaceuticals SA Buy Hold or Sell Recommendation
| MITPFDelisted Stock | USD 6.75 0.00 0.00% |
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding Mithra Pharmaceuticals SA is 'Not Rated'. Macroaxis provides Mithra Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MITPF positions.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. Note, we conduct extensive research on individual companies such as Mithra and provide practical buy, sell, or hold advice based on investors' constraints. Mithra Pharmaceuticals SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Mithra |
Execute Mithra Pharmaceuticals Buy or Sell Advice
The Mithra recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Mithra Pharmaceuticals SA. Macroaxis does not own or have any residual interests in Mithra Pharmaceuticals SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Mithra Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Mithra Pharmaceuticals Trading Alerts and Improvement Suggestions
| Mithra Pharmaceuticals is not yet fully synchronised with the market data | |
| Mithra Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Mithra Pharmaceuticals SA has accumulated 125.24 M in total debt with debt to equity ratio (D/E) of 9.62, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Mithra Pharmaceuticals has a current ratio of 0.78, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Mithra Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Mithra Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mithra Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mithra to invest in growth at high rates of return. When we think about Mithra Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 22.67 M. Net Loss for the year was (116.88 M) with profit before overhead, payroll, taxes, and interest of 6.94 M. | |
| Mithra Pharmaceuticals SA has accumulated about 29.3 M in cash with (74.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.59. | |
| Roughly 32.0% of Mithra Pharmaceuticals outstanding shares are owned by corporate insiders |
| Symbol | MITPF |
| Name | Mithra Pharmaceuticals SA |
| Type | Pink Sheet |
| Country | United States |
| Exchange | PINK |
Information on Mithra Pharmaceuticals SA Advice is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Thematic Opportunities
Explore Investment Opportunities
Mithra Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Mithra . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Mithra Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Mithra Pharmaceuticals SA? Buying financial instruments such as Mithra Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Mithra Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Semiconductor Thematic Idea Now
Semiconductor
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Mithra Pink Sheet
If you are still planning to invest in Mithra Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mithra Pharmaceuticals' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |